Melincoff Gwen A
Transaction: 06/01/2026
OTHER
Change
+8,621
Price
$1.86
Filing
06/03/2026
Type
OTHER
Chemomab Therapeutics Ltd.
CMMB • Biotechnology
$1.18
▲ +0.01 (+0.85%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$9.44M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 9.08Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.18
Change0.85%
Shares Out8.00M
Market Cap$9.44M
Enterprise Value$2.76M
52W Range1.35 - 4.12
Beta0.66
P/E-1.24
P/B1.09
P/FCF-0.84
EV/EBITDA-0.35
EV/FCF-0.25
Price$1.18
Change0.85%
Shares Out8.00M
Market Cap$9.44M
Enterprise Value$2.76M
52W Range1.35 - 4.12
Beta0.66
P/E-1.24
P/B1.09
P/FCF-0.84
EV/EBITDA-0.35
EV/FCF-0.25
Earnings Yield-80.50%
FCF Yield-118.82%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio9.08
Quick Ratio9.08
Volume81.06K
Avg Volume104.59K
EPS Surprise-0.18
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 9.08Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-10-21
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Mor George Adi
Transaction: 05/29/2026
SELL
Change
-18,750
Price
Not reported
Filing
06/01/2026
Type
SELL
Moses Alan Charles
Transaction: 03/16/2027
OTHER
Change
+5,172
Price
$2.14
Filing
04/10/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Melincoff Gwen A | OTHER | +8,621 | $1.86 | 06/01/2026 | 06/03/2026 |
| Mor George Adi | SELL | -18,750 | Not reported | 05/29/2026 | 06/01/2026 |
| Moses Alan Charles | OTHER | +5,172 | $2.14 | 03/16/2027 | 04/10/2026 |
| Cohen Neil Harris | OTHER | +5,172 | $2.14 | 03/16/2027 | 04/10/2026 |
| Darvish Nissim | OTHER | +6,599 | $5.24 | 06/01/2026 | 04/10/2026 |
| Lawler John | OTHER | +7,500 | $2.20 | 03/18/2026 | 04/10/2026 |
| Lawler John | OTHER | 0 | Not reported | 03/18/2026 | 04/10/2026 |
| Fatal Sigal | OTHER | +25,715 | $6.80 | 03/18/2026 | 04/10/2026 |
| Fatal Sigal | OTHER | 0 | Not reported | 03/18/2026 | 04/10/2026 |
| Moses Alan Charles | OTHER | +3,821 | $6.16 | 03/18/2026 | 04/10/2026 |
| Cohen Neil Harris | OTHER | +3,821 | $6.16 | 03/18/2026 | 04/10/2026 |
| Cohen Neil Harris | OTHER | 0 | Not reported | 03/18/2026 | 04/10/2026 |
| Darvish Nissim | OTHER | +4,221 | $3.44 | 03/18/2026 | 04/10/2026 |
| Darvish Nissim | OTHER | 0 | Not reported | 03/18/2026 | 04/10/2026 |
| Mor George Adi | OTHER | +8,431 | $3.20 | 03/18/2026 | 04/10/2026 |
| Mor George Adi | OTHER | 0 | Not reported | 03/18/2026 | 04/10/2026 |
| Nicaise Claude | OTHER | +5,172 | $2.14 | 03/16/2027 | 03/31/2026 |
| Quigley Jill M. | OTHER | +3,959 | $5.24 | 06/16/2026 | 03/31/2026 |
| Nicaise Claude | OTHER | +3,821 | $6.16 | 03/18/2026 | 03/31/2026 |
| Quigley Jill M. | OTHER | +2,533 | $4.00 | 03/18/2026 | 03/31/2026 |